KENNETH BATE - 17 Jun 2021 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Director
Signature
/s/ Brian Lynch, as attorney-in-fact for Kenneth Bate
Issuer symbol
MDGL
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 08:02:03 UTC
Previous filing
15 Jun 2021
Next filing
02 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDGL Stock Option (Right to Buy) Award $0 +12,489 $0.000000 12,489 17 Jun 2021 Common Stock 12,489 $105.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.